Recent pharmaceutical excessive pricing cases in context
Baker McKenzie competition head Fiona Carlin (Credit: Freedom Film LLC)
Baker McKenzie global antitrust head Fiona Carlin, assisted by Washington, DC, partner Creighton Macy and Johannesburg partner Nick Altini, examines international trends in excessive pricing enforcement against high generic drug prices - and considers whether the recent spike in activity could be a sign that enforcers are expanding the definition of the infringement.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now